My Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.

Press releases published on August 31, 2026

Aug. 31, 2026

Allogene Therapeutics Announces Participation in September Investor Conference

Indeterminate GlobeNewswire

Aug. 31, 2026

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD

Indeterminate GlobeNewswire

Aug. 31, 2026

Arch Biopartners Receives Central IRB Approval to Support U.S. Sites in Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial of LSALT Peptide

Indeterminate GlobeNewswire

Aug. 31, 2026

Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026

Indeterminate GlobeNewswire

Aug. 31, 2026

The 2026 Prostate Cancer Awareness Month Campaign: 'Partners in Care: Through Diagnosis. Through Treatment. Together.'

Indeterminate EIN Presswire

Aug. 31, 2026

Technology Adoption on the Rise Among Canadian Seniors: Closing the Digital Gap

Indeterminate EIN Presswire

Aug. 31, 2026

Momcozy Launches Big Member Sale in Canada

Indeterminate EIN Presswire

Aug. 31, 2026

Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Aug. 31, 2026

Sofwave Announces Publication of Data from Randomized Controlled Study of its Pure Impact™ VIP Platform Utilizing PlyoPulse™ EMS Technology in Aesthetic Surgery Journal

Indeterminate GlobeNewswire

Aug. 31, 2026

OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

Aug. 31, 2026

Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia

Indeterminate GlobeNewswire

Aug. 31, 2026

Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

Indeterminate GlobeNewswire

Aug. 31, 2026

AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference

Indeterminate GlobeNewswire

Aug. 31, 2026

BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Indeterminate GlobeNewswire

Aug. 31, 2026

Revelyx Bio Launches to Advance YY003, an Investigational Recombinant Botulinum Toxin Type A in a Ready-to-Use Liquid Formulation

Indeterminate GlobeNewswire

Aug. 31, 2026

ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib

Indeterminate GlobeNewswire

Aug. 31, 2026

Teladoc Health Appoints Michael Grasher as Chief Financial Officer

Indeterminate GlobeNewswire

Aug. 31, 2026

Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference

Indeterminate GlobeNewswire

Aug. 31, 2026

Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions

Indeterminate GlobeNewswire

Aug. 31, 2026

Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray

Indeterminate GlobeNewswire